Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ulrike Protzer

Showing results (31-40 of 308) with videos related to

Pageof 31
Sort By:
Journal of Translational Medicine|June 20, 2020
Evaluation of T-activated proteins as recall antigens to monitor Epstein-Barr virus and human cytomegalovirus-specific T cells in a clinical trial settingNina Körber, Uta Behrends, Ulrike Protzer, et al.
Virology Journal|October 6, 2024
Adenoviral fiber-knob based vaccination elicits efficient neutralizing antibodies and T cell responses against adenovirus infectionAhmed Orabi, Kamyar Shameli, Ulrike Protzer, et al.
Clinical and Molecular Hepatology|October 21, 2024
Correspondence to editorial on "Genetically-modified, redirected T cells target hepatitis B surface antigen-positive hepatocytes and hepatocellular carcinoma lesions in a clinical setting"Shunda Du, Karin Wisskirchen, Ke Zhang, et al.
Nature Reviews. Immunology|February 25, 2012
Living in the liver: hepatic infectionsUlrike Protzer, Mala K Maini, Percy A Knolle
Methods in Molecular Biology (Clifton, N.J.)|December 16, 2016
Analyses of HBV cccDNA Quantification and ModificationYuchen Xia, Daniela Stadler, Chunkyu Ko, et al.
Journal of Virology|February 14, 2003
Presence of replicating virus in recombinant hepadnavirus stocks results from recombination and can be eliminated by the use of a packaging cell lineUta Klöcker, Heike Oberwinkler, Timo Kürschner, et al.
Trends in Pharmacological Sciences|August 11, 2014
New pharmacological strategies to fight enveloped virusesKarin Wisskirchen, Julie Lucifora, Thomas Michler, et al.
Genes|October 18, 2018
The Global Hepatitis B Virus Genotype Distribution Approximated from Available Genotyping DataStoyan Velkov, Jördis J Ott, Ulrike Protzer, et al.
Biomolecules|March 25, 2022
PD-L1 Silencing in Liver Using siRNAs Enhances Efficacy of Therapeutic Vaccination for Chronic Hepatitis BTill Bunse, Anna D Kosinska, Thomas Michler, et al.
Journal of Hepatology|June 22, 2025
Chimeric antigen receptor (CAR) T-cell therapy: Engineering immune cells to treat liver diseasesElmar Jaeckel, Scott L Friedman, Michael Hudecek, et al.
Pageof 31

Showing results (31-40 of 308) with videos related to

Sort By:
Pageof 31
Journal of Translational Medicine|June 20, 2020
Evaluation of T-activated proteins as recall antigens to monitor Epstein-Barr virus and human cytomegalovirus-specific T cells in a clinical trial settingNina Körber, Uta Behrends, Ulrike Protzer, et al.
Virology Journal|October 6, 2024
Adenoviral fiber-knob based vaccination elicits efficient neutralizing antibodies and T cell responses against adenovirus infectionAhmed Orabi, Kamyar Shameli, Ulrike Protzer, et al.
Clinical and Molecular Hepatology|October 21, 2024
Correspondence to editorial on "Genetically-modified, redirected T cells target hepatitis B surface antigen-positive hepatocytes and hepatocellular carcinoma lesions in a clinical setting"Shunda Du, Karin Wisskirchen, Ke Zhang, et al.
Nature Reviews. Immunology|February 25, 2012
Living in the liver: hepatic infectionsUlrike Protzer, Mala K Maini, Percy A Knolle
Methods in Molecular Biology (Clifton, N.J.)|December 16, 2016
Analyses of HBV cccDNA Quantification and ModificationYuchen Xia, Daniela Stadler, Chunkyu Ko, et al.
Journal of Virology|February 14, 2003
Presence of replicating virus in recombinant hepadnavirus stocks results from recombination and can be eliminated by the use of a packaging cell lineUta Klöcker, Heike Oberwinkler, Timo Kürschner, et al.
Trends in Pharmacological Sciences|August 11, 2014
New pharmacological strategies to fight enveloped virusesKarin Wisskirchen, Julie Lucifora, Thomas Michler, et al.
Genes|October 18, 2018
The Global Hepatitis B Virus Genotype Distribution Approximated from Available Genotyping DataStoyan Velkov, Jördis J Ott, Ulrike Protzer, et al.
Biomolecules|March 25, 2022
PD-L1 Silencing in Liver Using siRNAs Enhances Efficacy of Therapeutic Vaccination for Chronic Hepatitis BTill Bunse, Anna D Kosinska, Thomas Michler, et al.
Journal of Hepatology|June 22, 2025
Chimeric antigen receptor (CAR) T-cell therapy: Engineering immune cells to treat liver diseasesElmar Jaeckel, Scott L Friedman, Michael Hudecek, et al.
Pageof 31